News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Modern Hasen Pharma Invests $43.6 Million for Essential Drug Facility



10/21/2011 10:48:46 AM

October 25, 2011 -- Shanghai Modern Hasen (Shangqiu) Pharmaceutical, a subsidiary of Shanghai Modern Pharmaceutical , announced plans to invest 277 million RMB ($43.6 million) to build a production facility in Shangqiu, Henan province. The new plant will produce drugs that are listed on the essential drug list. More details....

Stock Symbol: (SHA: 600420)


Read at ChinaBio Today


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES